Narcolepsy Type 1 Is Associated with a Systemic Increase and Activation of Regulatory T Cells and with a Systemic Activation of Global T Cells
Year: 2017
Type: article
Study design: Observational Study
Abstract: Narcolepsy is a rare neurologic disorder characterized by excessive daytime sleepiness, cataplexy and disturbed nocturnal sleep patterns. Narcolepsy type 1 (NT1) has been shown to result from a selective loss of hypothalamic hypocretin-secreting neurons with patients typically showing low CSF-hypocretin levels (<110 pg/ml). This specific loss of hypocretin and the strong association with the HLA-DQB1*06:02 allele led to the hypothesis that NT1 could be an immune-mediated pathology. Moreover, susceptibility to NT1 has recently been associated with several pathogens, particularly with influenza A H1N1 virus either through infection or vaccination. The goal of this study was to compare peripheral blood immune cell populations in recent onset pediatric NT1 subjects (post or non-post 2009-influenza A H1N1 vaccination) to healthy donors. We demonstrated an increased number of central memory CD4+ T cells (CD62L+ CD45RA-) associated to an activated phenotype (increase in CD69 and CD25 expression) in NT1 patients. Percentage and absolute count of regulatory T cells (Tregs) in NT1 patients were increased associated with an activated phenotype (increase in GITR and LAP expression), and of activated memory phenotype. Cytokine production by CD4+ and CD8+ T cells after activation was not modified in NT1 patients. In H1N1 vaccinated NT1 patients, absolute counts of CD3+, CD8+ T cells, and B cells were increased compared to non-vaccinated NT1 patients. These results support a global T cell activation in NT1 patients and thus support a T cell-mediated autoimmune origin of NT1, but do not demonstrate the pathological role of H1N1 prophylactic vaccination. They should prompt further studies of T cells, particularly of Tregs (such as suppression and proliferation antigen specific assays, and also T-cell receptor sequencing), in NT1.
Source: PLoS ONE
Authors: Michel Lecendreux(Conceptualization, Investigation, Methodology, Resources, Validation, Writing – original draft, Writing – review & editing), Guillaume Churlaud(Investigation, Validation, Writing – original draft, Writing – review & editing), Fabien Pitoiset(Investigation, Validation), Armelle Regnault(Investigation, Validation), Tu Anh Tran(Conceptualization, Investigation, Methodology, Resources, Validation), Roland Liblau(Conceptualization, Investigation, Methodology, Resources, Validation), David Klatzmann(Conceptualization, Funding acquisition, Methodology, Project administration, Resources, Supervision), Michelle Rosenzwajg(Conceptualization, Methodology, Project administration, Resources, Supervision, Writing – original draft, Writing – review & editing)
Institutions: Assistance Publique – Hôpitaux de Paris, Hôpital Robert-Debré, Inserm, Sorbonne Université, Pitié-Salpêtrière Hospital, Immunologie - Immunopathologie - Immunothérapie, Université Pierre-et-Marie-Curie, Laboratoire d'hématologie, Centre Hospitalier Universitaire de Nîmes, Centre National de la Recherche Scientifique, Université Toulouse III - Paul Sabatier
Language: English
Subfield: Cognitive Neuroscience
Field: Neuroscience
Domain: Life Sciences
Open Access status: gold
Estimated APC paid: $1,529
OpenAlex ID: W2576654415
